All posts tagged ross camidge

  • 7511985228_f25433830a_o

    NEJM: Crizotinib Effective in Phase 1 Trial Against ROS1 Lung Cancer

    The New England Journal of Medicine reports positive results of a phase 1 clinical trial of the drug crizotinib against the subset of lung cancer marked by rearrangement of the gene ROS1.

Camidge.Slider.940x530
Ross Camidge, MD, chief of the Lung Cancer program at
the University of Colorado Cancer Center, helped to enroll Rabinowitz
in the phase 1 trial of a new ALK inhibitor.
Camidge
Ross Camidge, MD, PhD
Ross Camidge, teaching
Dandelion
2327090343_cfd56b7636_b
Camidge
Pills